Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q83196056 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235815.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q83196056 | ||
| 024 | ‡a 0000-0002-7569-409X ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q83196056 | ||
| 100 | 0 | ‡a Chi-Ho Lee ‡c researcher (ORCID 0000-0002-7569-409X) ‡9 en | |
| 400 | 0 | ‡a Chi-Ho Lee ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's A man with a blistering eruption and tuberculosis | ||
| 670 | ‡a Author's Acute thyroiditis: An under-recognized complication of parathyroidectomy in end-stage renal failure patients with secondary hyperparathyroidism | ||
| 670 | ‡a Author's An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels. | ||
| 670 | ‡a Author's Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma | ||
| 670 | ‡a Author's Biomarkers of progression in diabetic nephropathy: The past, present and future | ||
| 670 | ‡a Author's Cardiometabolic risk profile of participants with prediabetes diagnosed by HbA1c criteria in an urban Hong Kong Chinese population over 40 years of age. | ||
| 670 | ‡a Author's Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes | ||
| 670 | ‡a Author's Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria | ||
| 670 | ‡a Author's Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady | ||
| 670 | ‡a Author's Genetics of Apparently Sporadic Pheochromocytoma and Paraganglioma in a Chinese Population. | ||
| 670 | ‡a Author's Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study | ||
| 670 | ‡a Author's Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes. | ||
| 670 | ‡a Author's Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities. | ||
| 670 | ‡a Author's Obesity, adipokines and cancer: an update. | ||
| 670 | ‡a Author's One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives | ||
| 670 | ‡a Author's Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify Dysglycemia and Type 2 Diabetes Mellitus: A 15-Year Prospective Study in Chinese. | ||
| 670 | ‡a Author's Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus. | ||
| 670 | ‡a Author's The Potential Role of Preoperative Trabecular Bone Score in Predicting Changes in Bone Mineral Density After Parathyroidectomy | ||
| 670 | ‡a Author's Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population. | ||
| 670 | ‡a Author's Validation of the Pooled Cohort equations in a long-term cohort study of Hong Kong Chinese. | ||
| 670 | ‡a Author's Which creatinine-based estimated glomerular filtration rate equation best predicts all-cause mortality in Chinese subjects with type 2 diabetes? | ||
| 909 | ‡a (orcid) 000000027569409x ‡9 1 | ||
| 919 | ‡a cardiometabolicriskprofileofparticipantswithprediabetesdiagnosedbyhba1ccriteriainanurbanhongkongchinesepopulationover40yearsofage ‡A Cardiometabolic risk profile of participants with prediabetes diagnosed by HbA1c criteria in an urban Hong Kong Chinese population over 40 years of age. ‡9 1 | ||
| 919 | ‡a circulatingfibroblastgrowthfactor21levelspredictprogressivekidneydiseaseinsubjectswithtype2diabetesandnormoalbuminuria ‡A Circulating fibroblast growth factor 21 levels predict progressive kidney disease in subjects with type 2 diabetes and normoalbuminuria ‡9 1 | ||
| 919 | ‡a delayeddiagnosisof22q112deletionsyndromeinanadultchineselady ‡A Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady ‡9 1 | ||
| 919 | ‡a geneticsofapparentlysporadicpheochromocytomaandparagangliomainachinesepopulation ‡A Genetics of Apparently Sporadic Pheochromocytoma and Paraganglioma in a Chinese Population. ‡9 1 | ||
| 919 | ‡a hypoadiponectinemiaasanindependentpredictorfortheprogressionofcarotidatherosclerosisa5yearprospectivestudy ‡A Hypoadiponectinemia as an independent predictor for the progression of carotid atherosclerosis: a 5-year prospective study ‡9 1 | ||
| 919 | ‡a impactofgeneticlociidentifiedingenomewideassociationstudiesondiabeticretinopathyinchinesepatientswithtype2diabetes ‡A Impact of Genetic Loci Identified in Genome-Wide Association Studies on Diabetic Retinopathy in Chinese Patients With Type 2 Diabetes. ‡9 1 | ||
| 919 | ‡a obesityadipokinesandcanceranupdate ‡A Obesity, adipokines and cancer: an update. ‡9 1 | ||
| 919 | ‡a 1yearintotheclashofpandemicsofdiabetesandcovid19lessonslearntandfutureperspectives ‡A One year into the clash of pandemics of diabetes and COVID‐19: Lessons learnt and future perspectives ‡9 1 | ||
| 919 | ‡a optimalcutoffsofhomeostasismodelassessmentofinsulinresistancehomairtoidentifydysglycemiaandtype2diabetesmellitusa15yearprospectivestudyinchinese ‡A Optimal Cut-Offs of Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) to Identify Dysglycemia and Type 2 Diabetes Mellitus: A 15-Year Prospective Study in Chinese. ‡9 1 | ||
| 919 | ‡a roleofcirculatingfibroblastgrowthfactor21measurementinprimarypreventionofcoronaryheartdiseaseamongchinesepatientswithtype2diabetesmellitus ‡A Role of Circulating Fibroblast Growth Factor 21 Measurement in Primary Prevention of Coronary Heart Disease Among Chinese Patients With Type 2 Diabetes Mellitus. ‡9 1 | ||
| 919 | ‡a potentialroleofpreoperativetrabecularbonescoreinpredictingchangesinbonemineraldensityafterparathyroidectomy ‡A The Potential Role of Preoperative Trabecular Bone Score in Predicting Changes in Bone Mineral Density After Parathyroidectomy ‡9 1 | ||
| 919 | ‡a validationofthediabetesscreeningtoolsproposedbytheamericandiabetesassociationinanagingchinesepopulation ‡A Validation of the diabetes screening tools proposed by the American Diabetes Association in an aging Chinese population. ‡9 1 | ||
| 919 | ‡a validationofthepooledcohortequationsinalongtermcohortstudyofhongkongchinese ‡A Validation of the Pooled Cohort equations in a long-term cohort study of Hong Kong Chinese. ‡9 1 | ||
| 919 | ‡a whichcreatininebasedestimatedglomerularfiltrationrateequationbestpredictsallcausemortalityinchinesesubjectswithtype2diabetes ‡A Which creatinine-based estimated glomerular filtration rate equation best predicts all-cause mortality in Chinese subjects with type 2 diabetes? ‡9 1 | ||
| 919 | ‡a circulatingadipocytefattyacidbindingproteinconcentrationspredictmultiplemortalityoutcomesamongmenandwomenwithdiabetes ‡A Circulating Adipocyte Fatty Acid-Binding Protein Concentrations Predict Multiple Mortality Outcomes among Men and Women with Diabetes ‡9 1 | ||
| 919 | ‡a acutethyroiditisanunderrecognizedcomplicationofparathyroidectomyinendstagerenalfailurepatientswithsecondaryhyperparathyroidism ‡A Acute thyroiditis: An under-recognized complication of parathyroidectomy in end-stage renal failure patients with secondary hyperparathyroidism ‡9 1 | ||
| 919 | ‡a manwithablisteringeruptionandtuberculosis ‡A A man with a blistering eruption and tuberculosis ‡9 1 | ||
| 919 | ‡a managingnonalcoholicfattyliverdiseaseindiabeteschallengesandopportunities ‡A Managing non-alcoholic fatty liver disease in diabetes: Challenges and opportunities. ‡9 1 | ||
| 919 | ‡a exomechipassociationanalysisinchinesesubjectsrevealsafunctionalmissensevariantofgckrthatregulatesfgf21levels ‡A An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of GCKR That Regulates FGF21 Levels. ‡9 1 | ||
| 919 | ‡a androgendeprivationtherapyandfractureriskinchinesepatientswithprostatecarcinoma ‡A Androgen deprivation therapy and fracture risk in Chinese patients with prostate carcinoma ‡9 1 | ||
| 919 | ‡a biomarkersofprogressionindiabeticnephropathythepastpresentandfuture ‡A Biomarkers of progression in diabetic nephropathy: The past, present and future ‡9 1 | ||
| 996 | ‡2 SZ|159544505 | ||
| 996 | ‡2 ISNI|0000000055533577 | ||
| 996 | ‡2 ISNI|000000050542159X | ||
| 996 | ‡2 PTBNP|186179 | ||
| 996 | ‡2 CYT|AC000000024 | ||
| 996 | ‡2 ISNI|0000000491713814 | ||
| 996 | ‡2 ISNI|0000000460158977 | ||
| 996 | ‡2 RERO|A003507076 | ||
| 996 | ‡2 ISNI|0000000494014752 | ||
| 996 | ‡2 PLWABN|9810686879405606 | ||
| 996 | ‡2 ISNI|0000000064288534 | ||
| 996 | ‡2 LC|no2023095281 | ||
| 996 | ‡2 DNB|1089325827 | ||
| 996 | ‡2 LC|n 2007039586 | ||
| 996 | ‡2 LC|no2014008528 | ||
| 996 | ‡2 NLA|000035296936 | ||
| 996 | ‡2 ISNI|0000000492811176 | ||
| 996 | ‡2 ISNI|0000000460475235 | ||
| 996 | ‡2 BNF|16213758 | ||
| 996 | ‡2 DNB|1047836238 | ||
| 996 | ‡2 ISNI|0000000113311367 | ||
| 996 | ‡2 ISNI|0000000062419772 | ||
| 996 | ‡2 LC|no2016021440 | ||
| 996 | ‡2 ISNI|0000000067394551 | ||
| 996 | ‡2 ISNI|0000000120314806 | ||
| 996 | ‡2 LC|n 2013182427 | ||
| 996 | ‡2 ISNI|0000000465093738 | ||
| 996 | ‡2 NSK|000312753 | ||
| 996 | ‡2 NUKAT|n 96402616 | ||
| 996 | ‡2 LC|n 87811751 | ||
| 996 | ‡2 SKMASNL|vtls012603059 | ||
| 996 | ‡2 LC|no2003102746 | ||
| 996 | ‡2 ISNI|0000000473702206 | ||
| 996 | ‡2 LC|no2013105840 | ||
| 996 | ‡2 ISNI|0000000512524634 | ||
| 996 | ‡2 SUDOC|12869369X | ||
| 996 | ‡2 ISNI|0000000503854199 | ||
| 996 | ‡2 ISNI|0000000473972521 | ||
| 996 | ‡2 ISNI|0000000493246578 | ||
| 996 | ‡2 ISNI|000000047374297X | ||
| 996 | ‡2 ISNI|0000000476705904 | ||
| 996 | ‡2 NKC|ola20221155919 | ||
| 996 | ‡2 DNB|1131636317 | ||
| 996 | ‡2 ISNI|0000000479213630 | ||
| 996 | ‡2 SUDOC|172080541 | ||
| 996 | ‡2 PTBNP|1480001 | ||
| 996 | ‡2 ISNI|0000000493160619 | ||
| 996 | ‡2 ISNI|0000000460475323 | ||
| 996 | ‡2 NTA|364163313 | ||
| 996 | ‡2 LC|no2009086630 | ||
| 996 | ‡2 DNB|1044097205 | ||
| 996 | ‡2 ISNI|0000000493192397 | ||
| 996 | ‡2 ISNI|0000000505737834 | ||
| 996 | ‡2 ISNI|0000000493160192 | ||
| 996 | ‡2 DNB|134951115 | ||
| 996 | ‡2 ISNI|0000000493175626 | ||
| 996 | ‡2 NTA|235692093 | ||
| 996 | ‡2 NII|DA00097170 | ||
| 996 | ‡2 ISNI|0000000505715731 | ||
| 996 | ‡2 CAOONL|ncf12113720 | ||
| 996 | ‡2 ISNI|0000000505432467 | ||
| 996 | ‡2 ISNI|0000000059361469 | ||
| 996 | ‡2 ISNI|0000000505906909 | ||
| 996 | ‡2 ISNI|0000000492112789 | ||
| 996 | ‡2 SUDOC|155985388 | ||
| 996 | ‡2 PLWABN|9810647483005606 | ||
| 996 | ‡2 J9U|987007424526105171 | ||
| 996 | ‡2 LC|n 87131595 | ||
| 996 | ‡2 DNB|1295008963 | ||
| 996 | ‡2 ISNI|0000000002118679 | ||
| 996 | ‡2 ISNI|0000000493270332 | ||
| 996 | ‡2 ISNI|0000000492100112 | ||
| 996 | ‡2 NTA|175134502 | ||
| 996 | ‡2 ISNI|0000000494048047 | ||
| 996 | ‡2 BIBSYS|1669191003297 | ||
| 996 | ‡2 ISNI|0000000503709258 | ||
| 996 | ‡2 PLWABN|9813704814805606 | ||
| 996 | ‡2 LC|no2015126678 | ||
| 996 | ‡2 ISNI|0000000055236118 | ||
| 996 | ‡2 SUDOC|150086008 | ||
| 996 | ‡2 DNB|159544505 | ||
| 996 | ‡2 LC|n 97846086 | ||
| 996 | ‡2 LC|n 2016044792 | ||
| 996 | ‡2 ISNI|0000000464464832 | ||
| 996 | ‡2 ISNI|0000000473502896 | ||
| 996 | ‡2 ISNI|000000046089187X | ||
| 996 | ‡2 NUKAT|n 2020148402 | ||
| 996 | ‡2 ISNI|0000000468783427 | ||
| 996 | ‡2 NSK|000346432 | ||
| 996 | ‡2 BIBSYS|90196323 | ||
| 996 | ‡2 NTA|382969529 | ||
| 996 | ‡2 RERO|A008696039 | ||
| 996 | ‡2 BIBSYS|3056401 | ||
| 996 | ‡2 ISNI|0000000459450006 | ||
| 996 | ‡2 ISNI|0000000467861091 | ||
| 996 | ‡2 BNF|14115883 | ||
| 996 | ‡2 ISNI|0000000493246551 | ||
| 996 | ‡2 SUDOC|086001078 | ||
| 996 | ‡2 ISNI|0000000464382538 | ||
| 996 | ‡2 DNB|1160414459 | ||
| 996 | ‡2 ISNI|0000000457170203 | ||
| 996 | ‡2 BNF|12571178 | ||
| 996 | ‡2 LC|nr 97035248 | ||
| 996 | ‡2 BIBSYS|98005241 | ||
| 996 | ‡2 ISNI|0000000464523820 | ||
| 996 | ‡2 SUDOC|263466779 | ||
| 996 | ‡2 BIBSYS|7020291 | ||
| 996 | ‡2 ISNI|0000000428219039 | ||
| 996 | ‡2 SUDOC|201058189 | ||
| 996 | ‡2 ISNI|0000000504217087 | ||
| 996 | ‡2 ISNI|0000000494014584 | ||
| 996 | ‡2 NSK|000465795 | ||
| 996 | ‡2 NUKAT|n 2007118987 | ||
| 996 | ‡2 ISNI|0000000465091679 | ||
| 996 | ‡2 CAOONL|ncf12099237 | ||
| 996 | ‡2 DBC|87097962505427 | ||
| 996 | ‡2 ISNI|000000049324656X | ||
| 996 | ‡2 LC|no2009184957 | ||
| 996 | ‡2 NUKAT|n 2007008884 | ||
| 996 | ‡2 LC|no2017161290 | ||
| 996 | ‡2 ISNI|0000000513469614 | ||
| 996 | ‡2 PLWABN|9812795481005606 | ||
| 996 | ‡2 ISNI|0000000439714860 | ||
| 996 | ‡2 ISNI|0000000371288163 | ||
| 996 | ‡2 BIBSYS|14064642 | ||
| 996 | ‡2 CAOONL|ncf11640616 | ||
| 996 | ‡2 LC|n 88107921 | ||
| 996 | ‡2 J9U|987007447587805171 | ||
| 996 | ‡2 ISNI|0000000113955656 | ||
| 996 | ‡2 LC|n 80058967 | ||
| 996 | ‡2 BNE|XX4830325 | ||
| 996 | ‡2 J9U|987007455954905171 | ||
| 996 | ‡2 CYT|AC000580016 | ||
| 996 | ‡2 DNB|102020074X | ||
| 996 | ‡2 NTA|31309182X | ||
| 996 | ‡2 N6I|vtls000009409 | ||
| 996 | ‡2 LC|n 88241626 | ||
| 996 | ‡2 ISNI|0000000473377079 | ||
| 996 | ‡2 NDL|032103742 | ||
| 996 | ‡2 SUDOC|136809995 | ||
| 996 | ‡2 BNF|16736178 | ||
| 996 | ‡2 ISNI|0000000384733537 | ||
| 996 | ‡2 NKC|mzk2007390428 | ||
| 996 | ‡2 ISNI|0000000491971493 | ||
| 996 | ‡2 ISNI|0000000063939315 | ||
| 996 | ‡2 DNB|13223243X | ||
| 996 | ‡2 LC|nr 99008608 | ||
| 996 | ‡2 ISNI|0000000063709229 | ||
| 996 | ‡2 ISNI|0000000493027017 | ||
| 996 | ‡2 DNB|1024638421 | ||
| 996 | ‡2 ISNI|0000000480203800 | ||
| 996 | ‡2 LC|n 2004150223 | ||
| 996 | ‡2 ISNI|0000000073249852 | ||
| 996 | ‡2 LC|n 86820915 | ||
| 996 | ‡2 BNF|14486848 | ||
| 996 | ‡2 ISNI|0000000464601817 | ||
| 996 | ‡2 LC|no 99088727 | ||
| 996 | ‡2 BIBSYS|2121109 | ||
| 996 | ‡2 ISNI|0000000505845536 | ||
| 996 | ‡2 BIBSYS|12046475 | ||
| 996 | ‡2 NTA|130283029 | ||
| 996 | ‡2 ISNI|0000000390457145 | ||
| 996 | ‡2 J9U|987007456530405171 | ||
| 996 | ‡2 ISNI|0000000442803178 | ||
| 996 | ‡2 BNC|981061038059206706 | ||
| 996 | ‡2 CAOONL|ncf11466222 | ||
| 996 | ‡2 NUKAT|n 2012042248 | ||
| 996 | ‡2 LC|n 87905713 | ||
| 996 | ‡2 W2Z|1669191003297 | ||
| 996 | ‡2 ISNI|0000000509592345 | ||
| 996 | ‡2 ISNI|0000000084157451 | ||
| 996 | ‡2 NUKAT|n 2005134409 | ||
| 996 | ‡2 DNB|1091567743 | ||
| 996 | ‡2 NSK|000128385 | ||
| 996 | ‡2 LC|n 80106388 | ||
| 996 | ‡2 ISNI|0000000491626729 | ||
| 996 | ‡2 SUDOC|05963538X | ||
| 996 | ‡2 NUKAT|nx2023690127 | ||
| 996 | ‡2 ISNI|0000000468302953 | ||
| 996 | ‡2 CYT|AC000607365 | ||
| 996 | ‡2 ISNI|0000000464668923 | ||
| 996 | ‡2 ISNI|0000000117359958 | ||
| 996 | ‡2 LC|n 92119539 | ||
| 996 | ‡2 BNF|17028227 | ||
| 996 | ‡2 ISNI|0000000483582930 | ||
| 996 | ‡2 ISNI|0000000467992075 | ||
| 996 | ‡2 LC|no2012079800 | ||
| 996 | ‡2 LC|no2017115774 | ||
| 996 | ‡2 CYT|AC000527097 | ||
| 996 | ‡2 ISNI|0000000491682552 | ||
| 996 | ‡2 ISNI|0000000479079048 | ||
| 996 | ‡2 BNF|15605218 | ||
| 996 | ‡2 ISNI|0000000508228402 | ||
| 996 | ‡2 ISNI|0000000460132996 | ||
| 996 | ‡2 ISNI|0000000000425245 | ||
| 996 | ‡2 BNC|981058513424906706 | ||
| 996 | ‡2 LC|no2015075438 | ||
| 996 | ‡2 ISNI|0000000064061284 | ||
| 996 | ‡2 DNB|123363982X | ||
| 996 | ‡2 LC|no2012073318 | ||
| 996 | ‡2 BNF|15640756 | ||
| 996 | ‡2 BNF|12309063 | ||
| 996 | ‡2 BNF|17989699 | ||
| 996 | ‡2 LC|n 82038059 | ||
| 996 | ‡2 NUKAT|n 2021089125 | ||
| 996 | ‡2 DBC|87097969800211 | ||
| 996 | ‡2 ISNI|0000000504562753 | ||
| 996 | ‡2 ISNI|0000000491639941 | ||
| 996 | ‡2 DNB|1319043763 | ||
| 996 | ‡2 NKC|utb2011641484 | ||
| 996 | ‡2 BNF|15578158 | ||
| 996 | ‡2 DE633|pe30114708 | ||
| 996 | ‡2 LC|no2007066756 | ||
| 996 | ‡2 BIBSYS|90300487 | ||
| 996 | ‡2 ISNI|0000000051153032 | ||
| 996 | ‡2 SUDOC|12209932X | ||
| 996 | ‡2 ISNI|0000000505066989 | ||
| 996 | ‡2 LC|n 82212249 | ||
| 996 | ‡2 ISNI|0000000483483609 | ||
| 996 | ‡2 SUDOC|073431079 | ||
| 996 | ‡2 J9U|987007364513805171 | ||
| 996 | ‡2 DNB|1166451224 | ||
| 996 | ‡2 ISNI|000000051332487X | ||
| 996 | ‡2 RERO|A009046887 | ||
| 996 | ‡2 ISNI|0000000463437605 | ||
| 996 | ‡2 SUDOC|270817492 | ||
| 996 | ‡2 J9U|987007461691605171 | ||
| 996 | ‡2 LC|no2021054448 | ||
| 996 | ‡2 NUKAT|n 2006124574 | ||
| 996 | ‡2 ISNI|0000000491713902 | ||
| 996 | ‡2 ISNI|0000000467992112 | ||
| 996 | ‡2 CAOONL|ncf12121332 | ||
| 996 | ‡2 DNB|1089880979 | ||
| 996 | ‡2 DNB|1160688761 | ||
| 996 | ‡2 SUDOC|254134939 | ||
| 996 | ‡2 ISNI|0000000505795604 | ||
| 996 | ‡2 ISNI|0000000465025647 | ||
| 996 | ‡2 ISNI|0000000516774008 | ||
| 996 | ‡2 BIBSYS|90238213 | ||
| 996 | ‡2 LC|n 82269627 | ||
| 996 | ‡2 DNB|140454519 | ||
| 996 | ‡2 DNB|1132259258 | ||
| 996 | ‡2 CAOONL|ncf10279696 | ||
| 996 | ‡2 ISNI|0000000483547529 | ||
| 996 | ‡2 NDL|01115852 | ||
| 996 | ‡2 LC|no2024120552 | ||
| 996 | ‡2 CYT|AC000524186 | ||
| 996 | ‡2 CYT|AC000198774 | ||
| 996 | ‡2 NTA|073639230 | ||
| 996 | ‡2 ISNI|0000000481566697 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
